Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney

Renal Failure

Volumn 28, Issue 2, 2006, Pages 161-169

  Chander, Vikas ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acute renal failure (ARF); Glycerol; L NAME; Nitric oxide (No); Oxidative stress; Resveratrol; Rhabdomyolysis

Indexed keywords

CATALASE; CREATININE; ENZYME; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLYCEROL; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; PHYTOALEXIN; POLYPHENOL DERIVATIVE; RESVERATROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CLEARANCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY INJURY; MALE; MEASUREMENT; MORPHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL; URINE LEVEL;

ANIMALS; ENZYME INHIBITORS; GLYCEROL; KIDNEY FAILURE, ACUTE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; STILBENES;

EID: 33645543506     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500531112     Document Type: Article

References (44)

1. Curry SC, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med. 1989;18:1068-1084.
2. Salluzzo RF. Rhabdomyolysis. In: Rosenet AL, ed. Emergency Medicine: Concepts and Clinical Practice. St. Louis, Mo: Mosby; 1992.
3. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000;37:581-587.
4. Better OS, Stain JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med. 1990;322:825-827.
5. Ayer G, Grandchamp A, Wyler T, Truniger B. Intrarenal hemodynamics in glycerol-induced myohemoglobinuric acute renal failure in the rat. Circ Res. 1971;29:128-135.
6. Hsu CH, Kurtz TW, Waldinger TP. Cardiac output and renal blood flow in glycerol-induced acute renal failure in the rat. Circ Res. 1977;40:178-182.
7. Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens. 1994;12:625-631.
8. Mundel P, Bachmann S, Bader M, et al. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int. 1992;42:1017-1019.
9. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol. 1990;1:875-881.
10. King AJ, Troy JL, Anderson S, Neuringer JR, Gunning M, Brenner BM. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol. 1991;1:1271-1277.
11. Das DK, Sato M, Ray PS, et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res. 1999;25:115-120.
12. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Rad Biol Med. 1999;27:160-169.
13. Bertelli AA, Giovannini L, Bernini W, et al. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res. 1996;22:61-63.
14. Ferrero ME, Bertelli AA, Pellegatta F, Fulgenzi A, Corsi MM, Bertelli A. Phytoalexin resveratrol (3-4′-5-trihydroxy-stilbene) modulates granulocyte and monocyte endothelial adhesion. Transplant Proc. 1998;30:4191-4193.
15. Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol. 2000;131:711-720.
16. Giovannini L, Migliori M, Longoni BM, et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol. 2001;37:262-270.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem. 1979;95:351-357.
18. Varley H. The plasma proteins. In: Varley H, ed. Practical Clinical Biochemistry. Delhi: CBS; 1989:236-238.
19. Chander V, Singh D, Chopra K. Attenuation of glycerol-induced acute renal failure in rats by trimetazidine and deferoxamine. Pharmacology. 2003;67:41-48.
20. Jollow DJ, Mitchell LR, Zampaglione N, Gillete JR. Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology. 1974;11:151-156.
21. Claiborne A. In: Greenwald RA, ed. CRC Handbook of Methods for Oxygen Radical Reaserch. Boca Raton, Fla: CRC Press; 1985:283-287.
22. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978;186:189-195.
23. Bywaters RG, Beall D. Crush injuries with impairment of renal function. Br Med J. 1941;1:427-432.
24. Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Bursztein S, Better OS. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Int Med. 1984;144:277-280.
25. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974;291:807-811.
26. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314-326.
27. Dubrow A, Flamenbaum W, Brenner BM, Lazarus JM, eds. Acute Renal Failure. New York, Ny: Churchill Livingstone; 1988.
28. Venkatachalan MA, Rennke HG, Sandstorm DJ. The vascular basis for acute renal failure in the rat. Preglomerular and postglomerular vasoconstriction. Circ Res. 1976;38:267-269.
29. Valdivielso JM, Lopez-Novoa JM, Eleno N, Perez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol. 2000;78:476-482.
30. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988;255:F539-F544.
31. Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol. 1988;255:F438-F443.
32. Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanisms and therapeutic implications. J Clin Invest. 1992;90:711-716.
33. Abull-Ezz SR, Walker PD, Shah SV. Role of glutathione in an animal model of myoglobinuric acute renal failure. Proc Nat Acad Sci USA. 1991;88:9833-9837.
34. Nath KA, Balla G, Vercellotti GM, et al. Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest. 1992;90:267-270.
35. Oken DE, Arce ML, Wilson DR. Glycerol-induced hemoglobinuric acute renal failure in the rat. I. Micropuncture study of the development of oliguria. J Clin Invest. 1966;45:724-735.
36. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol. 1997;20:420-424.
37. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta. 1985;834:275-278.
38. Ragazzi E, Froldi G, Fassina G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol Res Comm. 1988;20:79-82.
39. Jayatilake GS, Jayasuriya H, Lee ES, et al. Kinase inhibitors from Polygonum cuspidatum. J Nat Prod. 1993;56:1805-1810.
40. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103-1104.
41. Rotondo S, Rajtar G, Manarini S, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 1998;123:1691-1699.
42. Fremont L. Biological effects of resveratrol. Life Sci. 2000;66:663-673.
43. Bradamante S, Barenghi L, Piccinini F, et al. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol. 2003;465:115-123.
44. Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both no-dependent and no-independent mechanisms. Free Rad Biol Med. 2004;36:774-781.